Version 1
: Received: 29 March 2022 / Approved: 31 March 2022 / Online: 31 March 2022 (10:01:28 CEST)
Version 2
: Received: 30 October 2022 / Approved: 31 October 2022 / Online: 31 October 2022 (09:27:48 CET)
How to cite:
Esquirol Caussa, J.; Herrero Vila, E.; Sánchez Aldeguer, J. Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints2022, 2022030404. https://doi.org/10.20944/preprints202203.0404.v2
Esquirol Caussa, J.; Herrero Vila, E.; Sánchez Aldeguer, J. Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints 2022, 2022030404. https://doi.org/10.20944/preprints202203.0404.v2
Esquirol Caussa, J.; Herrero Vila, E.; Sánchez Aldeguer, J. Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints2022, 2022030404. https://doi.org/10.20944/preprints202203.0404.v2
APA Style
Esquirol Caussa, J., Herrero Vila, E., & Sánchez Aldeguer, J. (2022). Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints. https://doi.org/10.20944/preprints202203.0404.v2
Chicago/Turabian Style
Esquirol Caussa, J., Elisabeth Herrero Vila and Josep Sánchez Aldeguer. 2022 "Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines" Preprints. https://doi.org/10.20944/preprints202203.0404.v2
Abstract
Primary and secondary cardiovascular prevention is less effective than expected due to the concern about polymedication by professionals and the lack of patient adherence to medications prescribed in the medium and long term. Polypills have been presented as a possible solution. A comprehensive bibliographic review is presented about polypills as mechanisms for facilitating adherence and a proposed guide for the use of polypills for the prevention of cardiovascular risk. 41 articles were included, showing options for the polypill as a method of primary and secondary cardiovascular prevention.The polypill increases therapeutic adherence in the medium and long term, also increasing the therapeutic results compared to the administration of the various drugs separately. Based on the evidence, a flow diagram is proposed for the prescription of a polypill.Polypills increase the effectiveness and adherence of patients to primary and secondary cardiovascular prevention programs, without increasing the cost of the intervention. The use of a polypill in cardiovascular prevention can be effective as a prescription tool.
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Commenter: Jordi Esquirol Caussa
Commenter's Conflict of Interests: Author